SEC Form 4 · accession 0001144204-17-011486
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Reichling
Officer — CHIEF FINANCIAL OFFICER
Period of report
Feb 23, 2017
Accepted (ET)
Feb 27, 2017 · 9:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3,F1 | $24.45 | Feb 23, 2017 | A | 7,836 | A | — | Feb 23, 2027 | Common Stock | 7,836 | 7,836 | D |
| Employee Stock Option (right to buy)F3,F2 | $24.45 | Feb 23, 2017 | A | 15,000 | A | — | Feb 23, 2027 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The options vest in twelve (12) equal monthly installments beginning on March 23, 2017.
- F2The options vest in five (5) equal annual installments on each anniversary of the date of grant beginning on February 23, 2018.
- F3The total number of stock options held by the reporting person was previously aggregated in Table II of the reporting person's previous Form 4s. The number of stock options reported on this Form 4 reflects only the number of stock options of the classes of securities reported herein.